These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 33354729)

  • 1. Membrane-embedded TSPO: an NMR view.
    Rivière G; Jaipuria G; Andreas LB; Leonov A; Giller K; Becker S; Zweckstetter M
    Eur Biophys J; 2021 Mar; 50(2):173-180. PubMed ID: 33354729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholesterol-mediated allosteric regulation of the mitochondrial translocator protein structure.
    Jaipuria G; Leonov A; Giller K; Vasa SK; Jaremko Ł; Jaremko M; Linser R; Becker S; Zweckstetter M
    Nat Commun; 2017 Mar; 8():14893. PubMed ID: 28358007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into Cholesterol/Membrane Protein Interactions Using Paramagnetic Solid-State NMR.
    Jaipuria G; Giller K; Leonov A; Becker S; Zweckstetter M
    Chemistry; 2018 Nov; 24(66):17606-17611. PubMed ID: 30255522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary and tertiary structures of the transmembrane domains of the translocator protein TSPO determined by NMR. Stabilization of the TSPO tertiary fold upon ligand binding.
    Murail S; Robert JC; Coïc YM; Neumann JM; Ostuni MA; Yao ZX; Papadopoulos V; Jamin N; Lacapère JJ
    Biochim Biophys Acta; 2008 Jun; 1778(6):1375-81. PubMed ID: 18420025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of the mitochondrial translocator protein in complex with a diagnostic ligand.
    Jaremko L; Jaremko M; Giller K; Becker S; Zweckstetter M
    Science; 2014 Mar; 343(6177):1363-6. PubMed ID: 24653034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural Prediction of the Dimeric Form of the Mammalian Translocator Membrane Protein TSPO: A Key Target for Brain Diagnostics.
    Zeng J; Guareschi R; Damre M; Cao R; Kless A; Neumaier B; Bauer A; Giorgetti A; Carloni P; Rossetti G
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30200318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct and specific binding of cholesterol to the mitochondrial translocator protein (TSPO) using PhotoClick cholesterol analogue.
    Georges E; Sottas C; Li Y; Papadopoulos V
    J Biochem; 2021 Oct; 170(2):239-243. PubMed ID: 33846725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Translocator protein (18 kDa) as a pharmacological target in adipocytes to regulate glucose homeostasis.
    Li J; Papadopoulos V
    Biochem Pharmacol; 2015 Sep; 97(1):99-110. PubMed ID: 26123521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigating the interactions of the 18kDa translocator protein and its ligand PK11195 in planar lipid bilayers.
    Hatty CR; Le Brun AP; Lake V; Clifton LA; Liu GJ; James M; Banati RB
    Biochim Biophys Acta; 2014 Mar; 1838(3):1019-30. PubMed ID: 24374318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A unified structural model of the mammalian translocator protein (TSPO).
    Xia Y; Ledwitch K; Kuenze G; Duran A; Li J; Sanders CR; Manning C; Meiler J
    J Biomol NMR; 2019 Jul; 73(6-7):347-364. PubMed ID: 31243635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Translocator protein (18 kDa): a promising therapeutic target and diagnostic tool for cardiovascular diseases.
    Qi X; Xu J; Wang F; Xiao J
    Oxid Med Cell Longev; 2012; 2012():162934. PubMed ID: 23251719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Translocator Protein (TSPO) in Mitochondrial Bioenergetics and Immune Processes.
    Betlazar C; Middleton RJ; Banati R; Liu GJ
    Cells; 2020 Feb; 9(2):. PubMed ID: 32102369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The translocator protein (18kDa) and its role in neuropsychiatric disorders.
    Barichello T; Simões LR; Collodel A; Giridharan VV; Dal-Pizzol F; Macedo D; Quevedo J
    Neurosci Biobehav Rev; 2017 Dec; 83():183-199. PubMed ID: 29054730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural requirements to obtain highly potent and selective 18 kDa Translocator Protein (TSPO) Ligands.
    Taliani S; Pugliesi I; Da Settimo F
    Curr Top Med Chem; 2011; 11(7):860-86. PubMed ID: 21291396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translocator protein (TSPO): the new story of the old protein in neuroinflammation.
    Lee Y; Park Y; Nam H; Lee JW; Yu SW
    BMB Rep; 2020 Jan; 53(1):20-27. PubMed ID: 31818362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translocator protein (TSPO) ligands for the diagnosis or treatment of neurodegenerative diseases: a patent review (2010 - 2015; part 2).
    Kim T; Pae AN
    Expert Opin Ther Pat; 2016 Nov; 26(11):1353-1366. PubMed ID: 27599163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translocator protein: pharmacology and steroidogenesis.
    Midzak A; Zirkin B; Papadopoulos V
    Biochem Soc Trans; 2015 Aug; 43(4):572-8. PubMed ID: 26551695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Cholesterol on the Stability of Monomeric and Dimeric Forms of the Translocator Protein TSPO: A Molecular Simulation Study.
    Si Chaib Z; Marchetto A; Dishnica K; Carloni P; Giorgetti A; Rossetti G
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32961709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An update into the medicinal chemistry of translocator protein (TSPO) ligands.
    Barresi E; Robello M; Costa B; Da Pozzo E; Baglini E; Salerno S; Da Settimo F; Martini C; Taliani S
    Eur J Med Chem; 2021 Jan; 209():112924. PubMed ID: 33081988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Interaction of Translocator Protein 18 kDa (TSPO) with NADPH Oxidase in Microglia.
    Loth MK; Guariglia SR; Re DB; Perez J; de Paiva VN; Dziedzic JL; Chambers JW; Azzam DJ; Guilarte TR
    Mol Neurobiol; 2020 Nov; 57(11):4467-4487. PubMed ID: 32743737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.